GDC-0152

SKU: orb1223778

Description

GDC-0152 is a potent antagonist of XIAP-BIR3, ML-IAP-BIR3, cIAP1-BIR3 and cIAP2-BIR3 with Ki of 28 nM, 14 nM, 17 nM and 43 nM, respectively; less affinity shown to cIAP1-BIR2 and cIAP2-BIR2. Phase 1. (In Vivo):GDC-0152 has moderate predicted hepatic clearance based on metabolic stability assays conducted using human liver microsomes. Plasma protein binding of GDC-0152 is moderate and comparable among mice (88 91%), rats (89 91%), dogs (81 90%), monkeys (76 85%), and humans (75 83%) over the range of concentrations investigated (0.1 100 μM); higher plasma protein binding is observed in rabbits (95 96%). GDC-0152 does not preferentially distribute to red blood cells with blood plasma partition ratios ranging from 0.6 to 1.1 in all species tested. The pharmacokinetics for GDC-0152 is achieved with a C max of 53.7 μM and AUC of 203.5 h·μM.

Key Properties

• CAS Number: 873652-48-3
• MW: 498.64
• Purity: >98% (HPLC)
• Formula: C₂₅H₃₄N₆O₃S
• SMILES: CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N1CCC[C@H]1C(=O)NC1=C(N=NS1)C1=CC=CC=C1 |r,c:28,34,36,t:26,32|
• Target: IAP
• Solubility: DMSO:99 mg/mL (198.54 mM); Ethanol:99 mg/mL (198.54 mM); Water:3 mg/mL (6.01 mM)

Storage & Handling

• Storage: Storage temperature: -20°C. Stability: ≥ 2 years
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Quick Database Links

Gene Symbol

IAP